VANCOUVER, BC, September 17, 2018 – VANC Pharmaceuticals Inc. (“VANC” or the “Company”) is pleased to announce the appointment of Philippe Ugnat as Strategic Advisor to help drive the corporate growth and strengthen the Company’s presence in the Province of Ontario and Québec.

Upon joining VANC as Strategic Advisor, Philippe said: “I’m excited to be joining VANC Pharmaceuticals and to leverage my background and experience to help with the growth and implementation of a forward thinking vision aimed at improving the overall delivery of healthcare. I see tremendous value in making breakthrough technology like the HealthTab point-of-care screening system readily accessible and enabling patients to have a hands-on approach to actively manage their physical and mental well-being”.

Philippe is a recognized leader known for crafting the requisite strategic vision to achieve business goals, rapidly increase company growth and shareholder value. Over the span of 20 years, Philippe has worked with startups to public companies and leveraged his broad international business and transactional experience to successfully develop, lead and implement innovative business solutions aimed at delivering growth through technology innovation and development, geographic expansion, strategic alliances, customer partnerships and mergers and acquisitions. He has worked has a lawyer in Ottawa and Toronto for several years and focused mainly on Initial Public Offerings, private and public equity and debt financings, mergers and acquisitions, corporate restructurings and reorganizations and corporate governance related matters.

Philippe holds a Bachelor of Laws, LL.B. and a Bachelor of Political Science from the University of Ottawa. He was called to the Bar of Ontario in 1998. Philippe will work closely with Bob Rai (CEO) and actively support the execution of the Company’s strategic vision while taking the lead on several high-profile initiatives, including setting up and managing relationships and alliances while analyzing potential growth opportunities for corporate fit and value creation.